US 7468419
Cyclosporin derivatives for the treatment of immune disorders
granted A61KA61K38/13A61P
Quick answer
US patent 7468419 (Cyclosporin derivatives for the treatment of immune disorders) held by Enanta Pharmaceuticals, Inc. expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/13, A61P, A61P43/00